Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2022 16:00 ET | Source: INVENTIVA

Inventiva announces the presentation of a scientific abstract at the next International Conference on Fatty Liver

Daix (France), Long Island City (New York, United States), April 7, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral...
April 07, 2022 11:45 ET | Source: Deinove

The second part of the Phase II clinical trial of DNV3837 in Clostridioides difficile infections to be extended to Canada

The second part of the Phase II clinical trial of DNV3837 in Clostridioides difficile infections to be extended to Canada The extension of the clinical trial in Canada will add 5 new sites to those...
April 07, 2022 11:45 ET | Source: Deinove

La 2ème partie de l’essai clinique de Phase II de DNV3837 dans les infections à Clostridioïdes difficile sera étendue au Canada

La 2ème partie de l’essai clinique de Phase II de DNV3837 dans les infections à Clostridioïdes difficile sera étendue au Canada L’extension de l’essai clinique au Canada permettra d’ajouter de 5...
April 05, 2022 06:45 ET | Source: Imara, Inc.

Imara Announces Results of Interim Analyses of Tovinontrine (IMR-687) Phase 2b Clinical Trials in Sickle Cell Disease and Beta-Thalassemia

Interim results in Ardent trial for sickle cell disease showed no significant difference in median annualized rate of vaso-occlusive crises in high-dose group versus placebo in an intent-to-treat...
April 04, 2022 14:38 ET | Source: Axiom Real-Time Metrics Inc

Axiom Exhibiting at Clinical Operations in Oncology Trials West Coast 2022

TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
March 31, 2022 17:15 ET | Source: The Rosen Law Firm PA

ROSEN, A LONGSTANDING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FIXX

NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
March 30, 2022 06:00 ET | Source: LTO Network

LTO Network Becomes the World's Premier Blockchain Network for eClinical Applications Through the Partnership of Triall With Crucial Data Solutions

AMSTERDAM, March 30, 2022 (GLOBE NEWSWIRE) -- LTO Network further solidifies its position as a key blockchain infrastructure provider to the clinical trial software (eClinical) space through its...
March 25, 2022 07:30 ET | Source: Arcutis Biotherapeutics, Inc.

Arcutis’ Roflumilast Foam Demonstrates Clinically Meaningful Results and Patient Quality of Life Improvements in Phase 2 Seborrheic Dermatitis Study

Previously reported data demonstrated that roflumilast foam provided statistically significant improvement in disease severity and a favorable safety and tolerability profileImprovement on...
March 25, 2022 07:30 ET | Source: Arcutis Biotherapeutics, Inc.

Arcutis Presents New Data on Once-Daily Roflumilast Cream for Plaque Psoriasis from DERMIS Phase 3 Trials at American Academy of Dermatology Annual Meeting

Pooled analysis of DERMIS-1 and DERMIS-2 demonstrated significantly more roflumilast-treated patients achieved Investigator Global Assessment (IGA) success (40%) at week 8 compared to vehicle (7%),...
March 24, 2022 07:30 ET | Source: Mydecine Innovations Group Inc.

Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study

DENVER, March 24, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a biotechnology company aiming to transform the...